Author

Abraham J. Langseth

Observed names: A. Langseth, A.J. Langseth, Abraham J Langseth, Abraham Langseth

Institution: SpringWorks Therapeutics (United States)

Observed institutions: Johns Hopkins University, University of California, San Francisco, Johns Hopkins Medicine, SpringWorks Therapeutics (United States)

ORCID: 0000-0003-2077-2828

Observed ORCID: 0000-0003-2077-2828

OpenAlex ID: A5045245802

Myelin remodeling through experience-dependent oligodendrogenesis in the adult somatosensory cortex

2018 · Ethan G. Hughes, Jennifer L. Orthmann-Murphy, et al. · Nature Neuroscience · 565

Transient Opening of the Mitochondrial Permeability Transition Pore Induces Microdomain Calcium Transients in Astrocyte Processes

2017 · Amit Agarwal, Pei-Hsun Wu, et al. · Neuron · 441

Sox10 directs neural stem cells toward the oligodendrocyte lineage by decreasing Suppressor of Fused expression

2010 · Christine D. Pozniak, Abraham J. Langseth, et al. · Proceedings of the National Academy of Sciences · 145

Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease

2015 · Jing Jin, Qi Peng, et al. · Human Molecular Genetics · 93

Wnts Influence the Timing and Efficiency of Oligodendrocyte Precursor Cell Generation in the Telencephalon

2010 · Abraham J. Langseth, Roeben N. Munji, et al. · Journal of Neuroscience · 63

Stage-specific control of oligodendrocyte survival and morphogenesis by TDP-43

2022 · Dongeun Heo, Jonathan P. Ling, et al. · eLife · 48

Olig2Ablation in Immature Oligodendrocytes Does Not Enhance CNS Myelination and Remyelination

2022 · Jiajia Wang, Lijun Yang, et al. · Journal of Neuroscience · 24

Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors

2022 · Andrew DJ. Pearson, Carl Allen, et al. · European Journal of Cancer · 17

Cell-type specific differences in promoter activity of the ALS-linked C9orf72 mouse ortholog

2017 · Abraham J. Langseth, Juhyun Kim, et al. · Scientific Reports · 12

Exth-102. Plasma and Cerebrospinal Fluid (csf) Pharmacokinetics (pk) of Mirdametinib in a Non-human Primate (nhp) Model

2022 · Cynthia Lester McCully, Todd Shearer, et al. · Neuro-Oncology · 1

[P2.06]: Wnts regulate the timing and efficiency of OPC generation in the telencephalon

2010 · A.J. Langseth, R.N. Munji, et al. · International Journal of Developmental Neuroscience · 1

Update from the Long-Term Follow-Up Phase of ReNeu: A Pivotal Phase 2b Trial of Mirdametinib in Adults and Children with Neurofibromatosis Type 1-Associated Symptomatic Plexiform Neurofibroma

2026 · A. Hirbe, H. Shuhaiber, et al. · Neuropediatrics

288MO Update from the long-term follow-up (LTFU) phase of ReNeu: A pivotal phase IIb trial of mirdametinib in adults and children with neurofibromatosis type 1 (NF1)-associated symptomatic plexiform neurofibroma (PN)

2026 · A. Hirbe, H. Shuhaiber, et al. · ESMO rare cancers.

Author response: Stage-specific control of oligodendrocyte survival and morphogenesis by TDP-43

2022 · Dongeun Heo, Jonathan P Ling, et al.

Regulation of the production and proliferation of oligodendrocyte progenitors in development and injury

2011 · Abraham J. Langseth · eScholarship (California Digital Library)

Works count: 15

Citation count: 1,409

H-index: 9

I10-index: 9